A5088875374- Venous Thromboembolism Diagnosis and Management
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Ischemic Stroke Management
- Intramuscular injections and effects
- Cerebral Venous Sinus Thrombosis
- Stroke Rehabilitation and Recovery
- Heart Failure Treatment and Management
- Tracheal and airway disorders
- Long-Term Effects of COVID-19
- Lipoproteins and Cardiovascular Health
- Multiple Sclerosis Research Studies
- Cardiovascular Function and Risk Factors
- Electrolyte and hormonal disorders
- Intracerebral and Subarachnoid Hemorrhage Research
- Peripheral Artery Disease Management
- Medical Imaging and Analysis
- Diabetes and associated disorders
- Peripheral Neuropathies and Disorders
- Cerebrovascular and Carotid Artery Diseases
- Pulmonary Hypertension Research and Treatments
- Platelet Disorders and Treatments
- Trauma Management and Diagnosis
- Adrenal Hormones and Disorders
Oslo University Hospital
2021-2024
Ullevål Sykehusapotek
2017
University Hospital of North Norway
2013
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The were health care workers 32 54 years age. All had high levels antibodies platelet factor 4-polyanion complexes; however, they no previous exposure heparin. Because cases occurred a population more than 130,000 vaccinated persons, we propose that represent rare...
During a 2-week period, we have encountered five cases presenting with the combination of cerebral venous thrombosis (CVT), intracerebral hemorrhage and thrombocytopenia. A clinical hallmark was rapid severe progression disease in spite maximum treatment efforts, resulting fatal outcome for 4 out 5 patients. All had received ChAdOx1 nCov-19 vaccine 1–2 weeks earlier developed characteristic syndrome thereafter. The progressive course high fatality rate CVT thrombocytopenia such cluster...
Mechanical thrombectomy is now the standard treatment for acute ischaemic stroke with occlusion of a carotid or intercranial artery. With occlusions this type, thrombolytic often has limited effect. The therapeutic outcome use time-dependent, and personalised approach to indication always necessary. To achieve best possible results, main prerequisites are good clinical procedures, an optimal patient pathway, high neuroradiological competence coordinated, interdisciplinary teams.
Abstract Background and aim The thrombectomy in the elderly prediction score (TERPS) for functional outcome after anterior circulation endovascular therapy (EVT) patients ≥ 80 years was recently developed. of this study to assess predictors validate model. Methods Consecutive treated with EVT from Oslo Acute Reperfusion Stroke Study were evaluated inclusion. Clinical radiological parameters used calculate TERPS, assessed at 3-month follow-up. Results Out 1028 who underwent acute ischemic...
Using a standard 3D nnUNET model that was pretrained to segment WMH on FLAIR, we obtained good stroke lesion segmentation accuracy (median Dice = 0.80) when the re-trained DWI in smaller sample (N 82). Applying DWIs from 307 thrombectomy patients, found no association between pre-treatment volume and functional outcome at 90 days after thrombectomy. Our results indicate established assumption of size being strong predictor should be investigated further for patients receiving mechanical
Abstract Background and objectives New onset persistent headache has been reported following acute COVID-19 disease to some degree also after SARS-CoV-2 vaccination. Still, the mechanisms for these types are unclear. The purpose of this study was assess levels amyloid related biomarkers in patients with vaccine. Methods In prospective observational cohort, severe as dominating symptom (n=29) vaccination (n=31), had neurological assessments reassessments 6 months. Plasma precursor protein...